Seeing Is Believing
with an average price target of $20.33. This is a potential upside of $-1.22 (-5.66%) from yesterday's end of day stock price of $21.55.
Fusion Pharmaceuticals 's activity chart (see below) currently has 32 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.13% with an average time for these price targets to be met of 241.63 days.
Most recent stock forecast was given by YUAN ZHI from B. RILEY on 20-Mar-2024. First documented stock forecast 21-Jul-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Dec-2022
$13
$-8.55 (-39.68%)
$13
2 years 21 days ago
(20-Mar-2024)
3/4 (75%)
$-8.09 (-38.36%)
287
Buy Since 04-Mar-2024
$16
$-5.55 (-25.75%)
$16
2 years 21 days ago
(20-Mar-2024)
1/2 (50%)
$-5.09 (-24.13%)
15
Hold Since 19-Mar-2024
$10
$-11.55 (-53.60%)
2 years 22 days ago
(19-Mar-2024)
0/1 (0%)
$-11.18 (-52.79%)
Buy Since 21-Jul-2020
$10
2 years 22 days ago
(19-Mar-2024)
5/6 (83.33%)
$6.75 (207.69%)
861
Buy Since 16-Sep-2022
$11
$-10.55 (-48.96%)
2 years 22 days ago
(19-Mar-2024)
1/2 (50%)
$-10.18 (-48.06%)
496
What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?
Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?
Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?